ELAN — ELANCO ANIMAL HEALTH INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ELANCO ANIMAL HEALTH INC (ELAN)
ELANCO ANIMAL HEALTH INC (ELAN) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $194M. Across recent filings, tracked investors recorded 1 new positions, 1 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ELAN
How many top investors track ELAN
A small number of top investors own this.
ELAN Ownership Composition
How ELANCO ANIMAL HEALTH INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting ELAN
- Izzy EnglanderMar 31, 2026Millennium ManagementShares834KValue$20M% Portfolio0.01%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares4.6MValue$109.6M% Portfolio0.02%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares86.2KValue$2.1M% Portfolio0.01%
Recent activity
- Increased$2.1M(288.98%)May 15, 2026
- New$501.4KFeb 13, 2026
Frequently asked questions
- How many institutional investors hold ELAN?
- 3 tracked institutional investors disclosed a position in ELAN (ELANCO ANIMAL HEALTH INC) in their most recent 13F filing.
- Who is the largest institutional holder of ELAN?
- Izzy Englander, Millennium Management, holds the largest disclosed position in ELAN, valued at $194M.
- Did institutional ownership of ELAN increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 1 increased, 0 reduced, and 0 fully exited ELAN.
- Where does this ELAN ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.